260 related articles for article (PubMed ID: 1327817)
1. Comparison of angiotensin-converting enzyme inhibitors in the rat in perfused hindlimbs and in vivo.
Nelissen-Vrancken MH; Leenders PJ; Bost JG; Struijker-Boudier HA; Smits JF
Eur J Pharmacol; 1992 Jun; 217(1):49-55. PubMed ID: 1327817
[TBL] [Abstract][Full Text] [Related]
2. Vascular angiotensin-converting enzyme expression regulates local angiotensin II.
Müller DN; Bohlender J; Hilgers KF; Dragun D; Costerousse O; Ménard J; Luft FC
Hypertension; 1997 Jan; 29(1 Pt 1):98-104. PubMed ID: 9039087
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a captopril-sensitive angiotensin converting enzyme in the hindquarter vasculature of SHR and WKY.
Mueller SM; Cohen ML
Artery; 1985; 12(6):337-45. PubMed ID: 2996465
[TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
Haddad G; Garcia R
J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
[TBL] [Abstract][Full Text] [Related]
5. Differential systemic and regional hemodynamic profiles of four angiotensin-I converting-enzyme inhibitors in the rat.
Richer C; Doussau MP; Giudicelli JF
Cardiovasc Drugs Ther; 1989 Dec; 3(6):865-72. PubMed ID: 2562138
[TBL] [Abstract][Full Text] [Related]
6. Release of angiotensin-(1-7) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition.
Chappell MC; Gomez MN; Pirro NT; Ferrario CM
Hypertension; 2000 Jan; 35(1 Pt 2):348-52. PubMed ID: 10642323
[TBL] [Abstract][Full Text] [Related]
7. Renal hemodynamic effects of nonhypotensive doses of angiotensin-converting enzyme inhibitors in hypertension and heart failure rats.
Nelissen-Vrancken HJ; Struijker-Boudier HA; Smits JF
J Cardiovasc Pharmacol; 1992 Feb; 19(2):163-8. PubMed ID: 1376783
[TBL] [Abstract][Full Text] [Related]
8. Effects of angiotensin II and angiotensin converting enzyme inhibitors on contractile and growth responses in isolated carotid arteries of the rat.
Schiffers PM; Struyker-Boudier HA; De Mey JG
Basic Res Cardiol; 1991; 86 Suppl 1():83-9. PubMed ID: 1645165
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
Baum T; Becker FT; Sybertz EJ
Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors.
Subissi A; Criscuoli M; Sardelli G; Guelfi M; Giachetti A
J Cardiovasc Pharmacol; 1992 Jul; 20(1):139-46. PubMed ID: 1383623
[TBL] [Abstract][Full Text] [Related]
11. Decreased vascular responsiveness produced by angiotensin-converting enzyme inhibitors in the rat isolated kidney.
Chiba S; Quilley CP; McGiff JC
Hypertension; 1982; 4(3 Pt 2):80-5. PubMed ID: 6175573
[TBL] [Abstract][Full Text] [Related]
12. The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril.
Essig J; Belz GG; Wellstein A
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):217S-223S. PubMed ID: 2548551
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
[TBL] [Abstract][Full Text] [Related]
14. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
Jorde UP; Ennezat PV; Lisker J; Suryadevara V; Infeld J; Cukon S; Hammer A; Sonnenblick EH; Le Jemtel TH
Circulation; 2000 Feb; 101(8):844-6. PubMed ID: 10694521
[TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin converting enzyme inhibitors on the vasoconstrictor action of angiotensin I on isolated rat kidney.
Schmidt M; Giesen-Crouse EM; Krieger JP; Welsch C; Imbs JL
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S100-5. PubMed ID: 2438482
[TBL] [Abstract][Full Text] [Related]
16. Converting-enzyme inhibitors increase converting-enzyme mRNA and activity in endothelial cells.
King SJ; Oparil S
Am J Physiol; 1992 Oct; 263(4 Pt 1):C743-9. PubMed ID: 1329541
[TBL] [Abstract][Full Text] [Related]
17. Increased responsiveness of the vascular bed to angiotensin I, angiotensin II and phenylephrine in acute and chronic ischemic hindlimbs in rats.
Nelissen-Vrancken HJ; Leenders PJ; Struijker Boudier HA; Smits JF
J Vasc Res; 1992; 29(5):359-66. PubMed ID: 1330017
[TBL] [Abstract][Full Text] [Related]
18. Local generation of angiotensin II as a mechanism of aldosterone secretion in rat adrenal capsules.
Oda H; Lotshaw DP; Franco-Saenz R; Mulrow PJ
Proc Soc Exp Biol Med; 1991 Feb; 196(2):175-7. PubMed ID: 1846675
[TBL] [Abstract][Full Text] [Related]
19. Captopril improves postresuscitation hemodynamics protective against pulmonary embolism by activating the ACE2/Ang-(1-7)/Mas axis.
Xiao HL; Li CS; Zhao LX; Yang J; Tong N; An L; Liu QT
Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1159-1169. PubMed ID: 27449068
[TBL] [Abstract][Full Text] [Related]
20. Different modulation of steroidogenesis and prostaglandin production in frog ovary in vitro by ACE and ANG II.
Bramucci M; Miano A; Gobbetti A; Zerani M; Quassinti L; Maccari E; Murri O; Amici D
Am J Physiol; 1997 Dec; 273(6):R2089-96. PubMed ID: 9435665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
